Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Cardiac Surgery-Associated Acute Kidney Injury and Its Correlation with Long-Term Major Adverse Events

• Main Authors: Miaolin Che (Author), Xudong Wang (Author), Bo Xie (Author), Ritai Huang (Author), Shang Liu (Author), Yucheng Yan (Author), Mingli Zhu (Author), Renhua Lu (Author), Jiaqi Qian (Author), Weiming Zhang (Author), Leyi Gu (Author), Shan Mou (Author), Zhaohui Ni (Author), Song Xue (Author)
• Format: Book
• Published: Karger Publishers, 2019-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/Aims: Cardiac surgery-associated acute kidney injury (CSA-AKI) was traditionally defined as an increase in serum creatinine (sCr) after cardiac surgery. Recently, serum cystatin C (sCyC) has been proposed to be a better biomarker in the prediction of AKI. The clinical utility and performa...